Table 1.
Summary of all studies reviewed.
| Author | Year | Country | Total Population | NB Gender Present | Number of NB Participants | Overall Gender Distribution | Overall Acceptance Rate (%) | Acceptance Rate in NB Participants (%) |
|---|---|---|---|---|---|---|---|---|
| Freeman et al. [9] | 2020 | UK | 5114 | Yes | 20 | M = 2574, F = 2515 | 71.71% | - |
| Lazarus et al. [10] | 2021 | China | 712 | Yes | 0 | M = 360, F = 351 | 88.62% | - |
| Lazarus et al. [10] | 2021 | Brazil | 717 | Yes | 4 | M = 276, F = 436 | 85.36% | - |
| Lazarus et al. [10] | 2021 | Canada | 707 | Yes | 6 | M = 307, F = 392 | 68.74% | - |
| Lazarus et al. [10] | 2021 | Ecuador | 741 | Yes | 10 | M = 323, F = 407 | 71.93% | - |
| Lazarus et al. [10] | 2021 | France | 669 | Yes | 2 | M = 334, F = 333 | 58.89% | - |
| Lazarus et al. [10] | 2021 | Germany | 722 | Yes | 2 | M = 298, F = 417 | 68.42% | - |
| Lazarus et al. [10] | 2021 | India | 742 | Yes | 6 | M = 243, F = 485 | 74.53% | - |
| Lazaus et al. [10] | 2021 | Italy | 736 | Yes | 1 | M = 323, F = 412 | 70.79% | - |
| Lazarus et al. [10] | 2021 | Mexico | 699 | Yes | 2 | M = 332, F = 364 | 76.25% | - |
| Lazarus et al. [10] | 2021 | Nigeria | 670 | Yes | 22 | M = 275, F = 373 | 65.22% | - |
| Lazarus et al. [10] | 2021 | Poland | 666 | Yes | 0 | M = 362, F = 302 | 56.31% | - |
| Lazarus et al. [10] | 2021 | Russia | 680 | Yes | 6 | M = 328, F = 346 | 54.85% | - |
| Lazarus et al. [10] | 2021 | Singapore | 655 | Yes | 3 | M = 342, F = 310 | 67.94% | - |
| Lazarus et al. [10] | 2021 | South Africa | 619 | Yes | 3 | M = 321, F = 294 | 81.58% | - |
| Lazarus et al. [10] | 2021 | South Korea | 752 | Yes | 0 | M = 357, F = 392 | 79.79% | - |
| Lazarus et al. [10] | 2021 | Spain | 748 | Yes | 2 | M = 345, F = 401 | 74.33% | - |
| Lazarus et al. [10] | 2021 | Sweden | 650 | Yes | 2 | M = 322, F = 326 | 65.23% | - |
| Lazarus et al. [10] | 2021 | UK | 768 | Yes | 14 | M = 344, F = 408 | 71.48% | - |
| Lazarus et al. [10] | 2021 | USA | 773 | Yes | 9 | M = 337, F = 423 | 75.42% | - |
| Reiter et al. [11] | 2020 | USA | 2006 | Yes | 16 | M = 868, F = 1122 | 68.50% | 56.25% |
| Salali et al. [12] | 2020 | UK | 1088 | Yes | 31 | M = 322, F = 735 | 82.00% | - |
| Salali et al. [12] | 2020 | Turkey | 3936 | Yes | 18 | M = 1474, F = 2462 | 67.00% | - |
| Shekhar et al. [13] | 2020 | USA | 3479 | Yes | 7 | M = 864, F = 2598 | 36.00% | 43.00% |
| Teixeira da Silva et al. [14] | 2021 | USA | 1350 | Yes | 1262 | Not reported | Not reported; study focused on predictors of vaccine acceptance | Not reported; study focused on predictors of vaccine acceptance |
| Bendau et al. [15] | 2021 | Germany | 1779 | Yes | 10 | M = 389, F = 1380 | 64.50% | - |
| Kuter et al. [16] | 2021 | USA | 12034 | Yes | 878 | M = 5658, F = 1241 | 63.70% | 28.90% |
| Lin et al. [17] | 2021 | Taiwan | 1047 | Yes | 171 | M-430, F-617 | Sexual minority individuals had higher levels of explicit and intrinsic intention to receive COVID-19 vaccination relative to heterosexual individuals. | Not reported; multiple regression models were used |
NB, nonbinary; M, male; F, female.